Elan Corporation

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 28, 2005--Elan Corporation, plc announced that it will host a webcast later today at 11.30am Eastern Standard Time (EST), 4:30 p.m. Greenwich Mean Time (GMT) with the investment community to discuss Biogen Idec and Elan's announcement of a voluntary suspension of Tysabri.

Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to investors, members of the news media and the general public.

This event can be accessed by visiting Elan's website at www.elan.com and clicking on the Investor Relations section, then on the event icon. Following the live webcast, an archived version of the call will be available at the same URL.

About Elan

Elan Corporation, plc is a neuroscience-based biotechnology company. We are committed to making a difference in the lives of patients and their families by dedicating ourselves to bringing innovations in science to fill significant unmet medical needs that continue to exist around the world. Elan shares trade on the New York, London and Dublin Stock Exchanges. For additional information about the company, please visit http://www.elan.com.